Q1 2026 Holdings
Filed 2026-05-15 | 37 holdings | $105.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.3M | 22,550 | 6.9% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $6.9M | 41,000 | 6.6% |
| Praxis Precision Medicines I(PRAX)Put | COM NEW | 74006W207 | $6.6M | 20,500 | 6.3% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $5.9M | 1,025,000 | 5.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.6M | 276,750 | 5.3% |
| Amicus Therapeutic(FOLD) | COM | 03152W109 | $5.3M | 369,000 | 5.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.6M | 82,000 | 4.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $4.3M | 820,000 | 4.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.7M | 174,250 | 3.5% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $3.5M | 55,350 | 3.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.3M | 57,400 | 3.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $3.3M | 82,000 | 3.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $3.3M | 110,700 | 3.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.2M | 174,250 | 3.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $2.9M | 1,230,000 | 2.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $2.8M | 57,400 | 2.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.7M | 123,000 | 2.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.7M | 451,000 | 2.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.2M | 82,000 | 2.1% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $2.2M | 82,000 | 2.1% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $2.1M | 102,500 | 2.0% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $2.0M | 82,000 | 1.9% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $2.0M | 49,200 | 1.9% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.9M | 142,000 | 1.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.7M | 5,125 | 1.6% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $1.6M | 8,200 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.5M | 49,200 | 1.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $1.5M | 153,750 | 1.4% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $1.4M | 902,000 | 1.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.4M | 57,400 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.3M | 102,500 | 1.2% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.2M | 36,900 | 1.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $965.3K | 174,250 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $819.7K | 24,600 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $740.4K | 140,500 | 0.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $698.3K | 10,250 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $269.4K | 820,000 | 0.3% |